{"ticker": {"uuid": "852fa7bd-ef2a-415a-b99c-90dd8ea091bc", "symbol": "PASW", "name": "Ping An Biomedical Co., Ltd.", "exchange": "NASDAQ", "country": "US", "sector": "Consumer Cyclical", "industry": "Textile Manufacturing"}, "articles": [{"title": "If You Invested $1,000 in Ping An Biomedical (PASW)", "summary": "This article analyzes the historical performance of Ping An Biomedical (PASW) stock, detailing that a $1,000 investment made at its trading inception in October 2025 would now be worth $154, representing an 85% loss. It also provides an overview of the company's business, which i", "url": "https://www.stocktitan.net/tools/stock-return-calculator/PASW", "source_name": "Stock Titan", "published_at": "2026-07-08T01:40:07", "published_display": "08 Jul 2026 01:40", "sentiment": "negative", "sentiment_pct": 38, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PASW - Ping An Biomedical Co Ltd Latest SEC Filings", "summary": "This article provides the latest SEC filings for Ping An Biomedical Co Ltd (PASW), along with detailed financial and stock performance data. It includes information on the company's last close price, percentage change, various financial ratios, insider ownership, and performance ", "url": "https://finviz.com/stock?t=PASW&ty=lf&p=d&b=1", "source_name": "Finviz", "published_at": "2026-07-04T06:09:59", "published_display": "04 Jul 2026 06:09", "sentiment": "negative", "sentiment_pct": 40, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ping An Biomedical Ord Shs", "summary": "", "url": "https://news.google.com/rss/articles/CBMibkFVX3lxTE1XenluTC1pS3QxQktDQU9HUS1EWTV2MnBBd3k3U0xwcDlRNVBvX3k1V2NId1Z3VTRxOUgzMThjQzFxQ0ZhNkhibUFsYW9feHp3d0s0YVlzU2t5QnhJT2taSXVJbVUxWTR2VXZnQW5R?oc=5", "source_name": "TradingKey", "published_at": "2026-06-18T09:24:37+00:00", "published_display": "18 Jun 2026 09:24", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ping An Biomedical receives Nasdaq extension to regain minimum bid compliance", "summary": "Ping An Biomedical Co., Ltd. (NASDAQ:BMED) has been granted an additional 180-day extension by Nasdaq to meet the minimum bid price requirement of $1 per share, setting a new deadline of November 23, 2026. The company had previously fallen out of compliance in late 2025 and plans", "url": "https://ng.investing.com/news/sec-filings/ping-an-biomedical-receives-nasdaq-extension-to-regain-minimum-bid-compliance-93CH-2532270", "source_name": "Investing.com Nigeria", "published_at": "2026-06-01T06:39:39", "published_display": "01 Jun 2026 06:39", "sentiment": "negative", "sentiment_pct": 38, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PASW - Ping An Biomedical Co Ltd Stock Price and Quote", "summary": "This page provides detailed stock information for Ping An Biomedical Co Ltd (PASW), including its last close price, percentage change, and key financial metrics. It covers various aspects like market capitalization, P/E ratio, trading volumes, and recent news headlines related to", "url": "https://finviz.com/stock?t=PASW", "source_name": "Finviz", "published_at": "2026-05-30T16:12:40", "published_display": "30 May 2026 16:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ping An Biomedical (MJID) granted 180-day Nasdaq extension to fix sub-$1 bid", "summary": "Ping An Biomedical Co., Ltd. (MJID) has received an additional 180-day extension from Nasdaq, until November 23, 2026, to regain compliance with the minimum $1 bid price requirement. The company's shares have been trading below this threshold, breaching Nasdaq Listing Rule 5550(a", "url": "https://www.stocktitan.net/sec-filings/MJID/6-k-ping-an-biomedical-co-ltd-current-report-foreign-issuer-7ad820713b2f.html", "source_name": "Stock Titan", "published_at": "2026-05-29T05:10:26", "published_display": "29 May 2026 05:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ping An Biomedical Wins Nasdaq Extension to Regain $1 Minimum Bid Price Compliance", "summary": "Ping An Biomedical has received an additional 180-day grace period from Nasdaq to regain compliance with the $1 minimum bid price requirement, extending the deadline until November 23, 2026. The company's shares failed to meet this requirement between October 10 and November 20, ", "url": "https://www.theglobeandmail.com/investing/markets/markets-news/Tipranks/2188471/ping-an-biomedical-wins-nasdaq-extension-to-regain-1-minimum-bid-price-compliance/", "source_name": "The Globe and Mail", "published_at": "2026-05-29T03:40:30", "published_display": "29 May 2026 03:40", "sentiment": "negative", "sentiment_pct": 38, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]", "summary": "Ping An Biomedical Co., Ltd. (NASDAQ: PASW) announced two significant developments via a Form 6-K filing on January 12, 2026. Firstly, the company secured strategic investments from several notable investors, including Yao Jinbo of 58 Group, Wang Donghui of Amiba Capital, and Li ", "url": "https://br.advfn.com/noticias/EDGAR2/2026/artigo/97597864", "source_name": "ADVFN", "published_at": "2026-04-13T19:40:25", "published_display": "13 Apr 2026 19:40", "sentiment": "positive", "sentiment_pct": 73, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ping An Biomedical Co., Ltd. (PASW) Competitors", "summary": "This article provides a detailed comparison of Ping An Biomedical Co., Ltd. (PASW) with its competitors in the Industrial - Distribution sector. It presents financial metrics such as market cap, P/E ratio, EPS, and dividend yield for PASW and several peer companies. The analysis ", "url": "https://meyka.com/stock/PASW/peers/", "source_name": "Meyka", "published_at": "2026-04-08T17:39:15", "published_display": "08 Apr 2026 17:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ping An Biomedical (PASW) CEO discloses 12.25M indirect share stake on Form 3", "summary": "Ping An Biomedical Co., Ltd. CEO Liu Pijun has filed an initial statement of beneficial ownership (Form 3), disclosing an indirect holding of 12,250,000 Class A Ordinary Shares through INSPIRETECH LTD. This filing establishes his initial ownership position as both a director and ", "url": "https://www.stocktitan.net/sec-filings/MJID/form-3-majestic-ideal-holdings-ltd-initial-statement-of-beneficial-ow-5040876473c6.html", "source_name": "Stock Titan", "published_at": "2026-04-08T11:09:45", "published_display": "08 Apr 2026 11:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PASW PE Ratio & Valuation, Is PASW Overvalued", "summary": "This article analyzes the valuation of Ping An Biomedical Co Ltd (PASW), stating it is currently in the \"Fair zone\" based on its forward PS ratio compared to its five-year average. It discusses various financial metrics such as Price-to-Book (P/B) ratio, Forward Free Cash Flow (F", "url": "https://intellectia.ai/en/stock/PASW/valuation", "source_name": "Intellectia AI", "published_at": "2026-04-04T14:39:06", "published_display": "04 Apr 2026 14:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PASW Stock News Today | Earnings, Events & Price Alerts", "summary": "This article provides recent news and events related to PASW (Ping An Biomedical Co.), including its stock performance and corporate actions. Key updates include shareholder approval for a significant capital structure overhaul, plans to sell 13.61 million ordinary shares, and in", "url": "https://intellectia.ai/en/stock/PASW/news", "source_name": "Intellectia AI", "published_at": "2026-04-04T12:39:06", "published_display": "04 Apr 2026 12:39", "sentiment": "positive", "sentiment_pct": 64, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PASW Financials: Revenue Breakdown, Margins & Competitor Comparison", "summary": "This article provides a financial overview of Ping An Biomedical Co Ltd (PASW), detailing its revenue breakdown, profitability margins, and key financial health indicators. It highlights the company's gross margin of 2.78%, operating margin of -43.05%, and net margin of -37.57%, ", "url": "https://intellectia.ai/en/stock/PASW/financials", "source_name": "Intellectia AI", "published_at": "2026-04-03T08:39:45", "published_display": "03 Apr 2026 08:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ping An Biomedical (PASW) director Liu Xianzhi disclosed on Form 3", "summary": "Ping An Biomedical Co., Ltd. (PASW) director Liu Xianzhi has filed a Form 3, identifying them as a director and reporting person. The filing indicates no insider purchases, sales, or other equity transactions, with zero net insider share transactions and no derivative positions o", "url": "https://www.stocktitan.net/sec-filings/MJID/form-3-majestic-ideal-holdings-ltd-initial-statement-of-beneficial-ow-093f5d5ab4c2.html", "source_name": "Stock Titan", "published_at": "2026-04-01T09:40:27", "published_display": "01 Apr 2026 09:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "All Resolutions Passed at Ping An Biomedical AGM, Clearing Path for Restructured Share Capital", "summary": "Ping An Biomedical Co., Ltd (NASDAQ: PASW) announced that its shareholders approved all five resolutions at the 2026 Annual General Meeting. These approvals lead to a major restructuring of the company's share capital, including the introduction of high-vote Class B shares, a sha", "url": "https://www.manilatimes.net/2026/03/19/tmt-newswire/globenewswire/all-resolutions-passed-at-ping-an-biomedical-agm-clearing-path-for-restructured-share-capital/2303855", "source_name": "The Manila Times", "published_at": "2026-03-23T01:38:58", "published_display": "23 Mar 2026 01:38", "sentiment": "positive", "sentiment_pct": 74, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ping An Biomedical (NASDAQ: PASW) OKs Class B shares and consolidation", "summary": "Ping An Biomedical shareholders approved a significant capital overhaul, including the creation of high-vote Class B shares and authorization for a future share consolidation. The move targets a specific transaction with major shareholder INSPIRETECH LTD, allowing them to exchang", "url": "https://www.stocktitan.net/sec-filings/MJID/6-k-majestic-ideal-holdings-ltd-current-report-foreign-issuer-31aa7fbc565e.html", "source_name": "Stock Titan", "published_at": "2026-03-19T15:10:16", "published_display": "19 Mar 2026 15:10", "sentiment": "negative", "sentiment_pct": 39, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ping An Bio clears plan to create shares with 100 votes each", "summary": "Ping An Biomedical (NASDAQ: PASW) shareholders approved all five AGM resolutions on March 18, 2026, authorizing a comprehensive capital restructure. Key actions include increasing authorized capital, creating 100,000,000 Class B shares with 100 votes each, a targeted exchange wit", "url": "https://www.stocktitan.net/news/PASW/all-resolutions-passed-at-ping-an-biomedical-agm-clearing-path-for-tjjo9rhpvjin.html", "source_name": "Stock Titan", "published_at": "2026-03-19T14:10:16", "published_display": "19 Mar 2026 14:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ping An Biomedical (PASW) director reports 599,400 indirect shares on Form 3", "summary": "Ping An Biomedical Co., Ltd. director Liu Qingxian has filed an initial insider ownership report (Form 3) disclosing an indirect ownership of 599,400 Class A Ordinary Shares through SONIC FLASH LIMITED. This filing indicates existing holdings rather than new purchases or sales. T", "url": "https://www.stocktitan.net/sec-filings/MJID/form-3-majestic-ideal-holdings-ltd-initial-statement-of-beneficial-ow-19fa05757e2a.html", "source_name": "Stock Titan", "published_at": "2026-03-18T14:08:36", "published_display": "18 Mar 2026 14:08", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ping An Biomedical (PASW) director Gao Jifeng files initial Form 3", "summary": "Gao Jifeng, a director at Ping An Biomedical Co., Ltd. (PASW), has filed an initial Statement of Beneficial Ownership of Securities (Form 3) with the SEC. The filing, dated March 18, 2026, indicates that Gao Jifeng does not beneficially own any non-derivative or derivative securi", "url": "https://www.stocktitan.net/sec-filings/MJID/form-3-majestic-ideal-holdings-ltd-initial-statement-of-beneficial-ow-82ba14881252.html", "source_name": "Stock Titan", "published_at": "2026-03-18T14:08:36", "published_display": "18 Mar 2026 14:08", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ping An Biomedical Calls March 18 AGM to Approve Dual-Class Shares and Major Share Consolidation", "summary": "Ping An Biomedical is holding its annual general meeting on March 18, 2026, to vote on significant changes to its capital structure, including the creation of dual-class shares. These changes involve increasing authorized capital to 5 billion ordinary shares, reclassifying most i", "url": "https://www.theglobeandmail.com/investing/markets/markets-news/Tipranks/669400/ping-an-biomedical-calls-march-18-agm-to-approve-dual-class-shares-and-major-share-consolidation/", "source_name": "The Globe and Mail", "published_at": "2026-03-09T01:38:57", "published_display": "09 Mar 2026 01:38", "sentiment": "negative", "sentiment_pct": 39, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PASW | Ping An Biomedical Co., Stock Data, Price & News", "summary": "This page provides comprehensive stock data for Ping An Biomedical Co., Ltd. (PASW), including real-time price, financials, insider trading activity, institutional holdings, and news. It also details the company's profile as a Cayman Islands-based holding company operating throug", "url": "https://www.quiverquant.com/stock/PASW/", "source_name": "Quiver Quantitative", "published_at": "2026-02-26T03:52:47", "published_display": "26 Feb 2026 03:52", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PASW | Ping An Biomedical Co., Institutional Ownership", "summary": "This page provides an overview of Ping An Biomedical Co., Ltd. (PASW) institutional ownership and related financial data. It details information such as insider trading activity, institutional and derivative holdings, whale activity, and features like Congress trading, corporate ", "url": "https://www.quiverquant.com/stock/PASW/institutions/", "source_name": "Quiver Quantitative", "published_at": "2026-02-22T02:52:33", "published_display": "22 Feb 2026 02:52", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "According to the latest documents disclosed by the US SEC, up to 13.6 million ordinary shares of Ping An Biomedical Co., Ltd. will be resold by its selling shareholders.", "summary": "The US SEC has disclosed that selling shareholders of Ping An Biomedical Co., Ltd. plan to resell up to 13.6 million ordinary shares. This significant share resale is expected to affect the company's equity structure, and market analysts are monitoring its potential impact on fut", "url": "https://www.bitget.com/news/detail/12560605199585", "source_name": "Bitget", "published_at": "2026-02-13T05:57:22", "published_display": "13 Feb 2026 05:57", "sentiment": "negative", "sentiment_pct": 36, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PASW SEC Filings - Ping An Biomedical 10-K, 10-Q, 8-K Forms", "summary": "This page provides access to Ping An Biomedical (PASW) SEC filings, including annual 10-K, quarterly 10-Q, and material event 8-K reports, offering detailed insights into the company's financials, operations, and risks. The company operates in both apparel supply chain management", "url": "https://www.stocktitan.net/sec-filings/PASW/", "source_name": "Stock Titan", "published_at": "2026-02-13T04:52:42", "published_display": "13 Feb 2026 04:52", "sentiment": "negative", "sentiment_pct": 38, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ping An Biomedical stock plunges after announcing $90 million investment plan By Investing.com", "summary": "Ping An Biomedical Co., Ltd (NASDAQ:PASW) stock plummeted 31% after announcing a strategic investment plan in Future Biotechnology Group. The plan involves an initial $30 million cash investment and subsequent acquisitions totaling $60 million, dependent on Future Biotechnology G", "url": "https://ca.investing.com/news/stock-market-news/ping-an-biomedical-stock-plunges-after-announcing-90-million-investment-plan-93CH-4394962", "source_name": "Investing.com Canada", "published_at": "2026-01-11T06:58:08", "published_display": "11 Jan 2026 06:58", "sentiment": "negative", "sentiment_pct": 20, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ping An Biomedical Co., Ltd Announces Strategic Investment in Future Biotechnology Group to Advance Collaborative Development of the Biopharmaceutical Industry", "summary": "Ping An Biomedical Co., Ltd (NASDAQ: PASW) announced a strategic non-binding investment memorandum with Future Biotechnology Group. The initial investment will be US$30 million in cash, with subsequent acquisitions up to US$60 million combining cash and consideration shares, cont", "url": "https://markets.financialcontent.com/ms.intelvalue/article/gnwcq-2026-1-9-ping-an-biomedical-co-ltd-announces-strategic-investment-in-future-biotechnology-group-to-advance-collaborative-development-of-the-biopharmaceutical-industry", "source_name": "FinancialContent", "published_at": "2026-01-10T12:32:12", "published_display": "10 Jan 2026 12:32", "sentiment": "positive", "sentiment_pct": 71, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ping An Biomedical (PASW) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE1xcXBwV1JES0xNdWFTLXFsQUNsYUlEdnBmbjRDcDNBSEtWRWxZSWVQTnFyb3VnNndpTnc5N29QZjMxdTgzeU1HV2k5QUJqNnJobEh3?oc=5", "source_name": "Stock Titan", "published_at": "2025-11-28T13:25:06+00:00", "published_display": "28 Nov 2025 13:25", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ping An Biomedical Co. Ltd. (NASDAQ: PASW) - Share Price", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxNNWYtN1BPZDNGWXlNSmdEdmo2bm5oaU5pS295emZ3WEw4NWE5bDg2Z3h1Ny1pdzZlU3JydmxwQUkyTHhMR0haTG9ZR256dDF5YktKaVpFSXJRWjdYdVZHTWZxX0VoS1BKVWU5RV85a2FYMmlrRVBUWXN1TTJVSzhPYUxPOEJqdGVpaHhlMUNUOTFoNkFneElHLUFxVQ?oc=5", "source_name": "intelligentinvestor.com.au", "published_at": "2025-10-02T10:15:09+00:00", "published_display": "02 Oct 2025 10:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "If You Invested $1,000 in Ping An Biomedical (PASW)", "summary": "This article analyzes the historical performance of Ping An Biomedical (PASW) stock, detailing that a $1,000 investment made at its trading inception in October 2025 would now be worth $154, representing an 85% loss. It also provides an overview of the company's business, which i", "url": "https://www.stocktitan.net/tools/stock-return-calculator/PASW", "source_name": "Stock Titan", "published_at": "2026-07-08T01:40:07", "published_display": "08 Jul 2026 01:40", "sentiment": "negative", "sentiment_pct": 38, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PASW - Ping An Biomedical Co Ltd Latest SEC Filings", "summary": "This article provides the latest SEC filings for Ping An Biomedical Co Ltd (PASW), along with detailed financial and stock performance data. It includes information on the company's last close price, percentage change, various financial ratios, insider ownership, and performance ", "url": "https://finviz.com/stock?t=PASW&ty=lf&p=d&b=1", "source_name": "Finviz", "published_at": "2026-07-04T06:09:59", "published_display": "04 Jul 2026 06:09", "sentiment": "negative", "sentiment_pct": 40, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ping An Biomedical Ord Shs", "summary": "", "url": "https://news.google.com/rss/articles/CBMibkFVX3lxTE1XenluTC1pS3QxQktDQU9HUS1EWTV2MnBBd3k3U0xwcDlRNVBvX3k1V2NId1Z3VTRxOUgzMThjQzFxQ0ZhNkhibUFsYW9feHp3d0s0YVlzU2t5QnhJT2taSXVJbVUxWTR2VXZnQW5R?oc=5", "source_name": "TradingKey", "published_at": "2026-06-18T09:24:37+00:00", "published_display": "18 Jun 2026 09:24", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ping An Biomedical receives Nasdaq extension to regain minimum bid compliance", "summary": "Ping An Biomedical Co., Ltd. (NASDAQ:BMED) has been granted an additional 180-day extension by Nasdaq to meet the minimum bid price requirement of $1 per share, setting a new deadline of November 23, 2026. The company had previously fallen out of compliance in late 2025 and plans", "url": "https://ng.investing.com/news/sec-filings/ping-an-biomedical-receives-nasdaq-extension-to-regain-minimum-bid-compliance-93CH-2532270", "source_name": "Investing.com Nigeria", "published_at": "2026-06-01T06:39:39", "published_display": "01 Jun 2026 06:39", "sentiment": "negative", "sentiment_pct": 38, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PASW - Ping An Biomedical Co Ltd Stock Price and Quote", "summary": "This page provides detailed stock information for Ping An Biomedical Co Ltd (PASW), including its last close price, percentage change, and key financial metrics. It covers various aspects like market capitalization, P/E ratio, trading volumes, and recent news headlines related to", "url": "https://finviz.com/stock?t=PASW", "source_name": "Finviz", "published_at": "2026-05-30T16:12:40", "published_display": "30 May 2026 16:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ping An Biomedical (MJID) granted 180-day Nasdaq extension to fix sub-$1 bid", "summary": "Ping An Biomedical Co., Ltd. (MJID) has received an additional 180-day extension from Nasdaq, until November 23, 2026, to regain compliance with the minimum $1 bid price requirement. The company's shares have been trading below this threshold, breaching Nasdaq Listing Rule 5550(a", "url": "https://www.stocktitan.net/sec-filings/MJID/6-k-ping-an-biomedical-co-ltd-current-report-foreign-issuer-7ad820713b2f.html", "source_name": "Stock Titan", "published_at": "2026-05-29T05:10:26", "published_display": "29 May 2026 05:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ping An Biomedical Wins Nasdaq Extension to Regain $1 Minimum Bid Price Compliance", "summary": "Ping An Biomedical has received an additional 180-day grace period from Nasdaq to regain compliance with the $1 minimum bid price requirement, extending the deadline until November 23, 2026. The company's shares failed to meet this requirement between October 10 and November 20, ", "url": "https://www.theglobeandmail.com/investing/markets/markets-news/Tipranks/2188471/ping-an-biomedical-wins-nasdaq-extension-to-regain-1-minimum-bid-price-compliance/", "source_name": "The Globe and Mail", "published_at": "2026-05-29T03:40:30", "published_display": "29 May 2026 03:40", "sentiment": "negative", "sentiment_pct": 38, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]", "summary": "Ping An Biomedical Co., Ltd. (NASDAQ: PASW) announced two significant developments via a Form 6-K filing on January 12, 2026. Firstly, the company secured strategic investments from several notable investors, including Yao Jinbo of 58 Group, Wang Donghui of Amiba Capital, and Li ", "url": "https://br.advfn.com/noticias/EDGAR2/2026/artigo/97597864", "source_name": "ADVFN", "published_at": "2026-04-13T19:40:25", "published_display": "13 Apr 2026 19:40", "sentiment": "positive", "sentiment_pct": 73, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ping An Biomedical Co., Ltd. (PASW) Competitors", "summary": "This article provides a detailed comparison of Ping An Biomedical Co., Ltd. (PASW) with its competitors in the Industrial - Distribution sector. It presents financial metrics such as market cap, P/E ratio, EPS, and dividend yield for PASW and several peer companies. The analysis ", "url": "https://meyka.com/stock/PASW/peers/", "source_name": "Meyka", "published_at": "2026-04-08T17:39:15", "published_display": "08 Apr 2026 17:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ping An Biomedical (PASW) CEO discloses 12.25M indirect share stake on Form 3", "summary": "Ping An Biomedical Co., Ltd. CEO Liu Pijun has filed an initial statement of beneficial ownership (Form 3), disclosing an indirect holding of 12,250,000 Class A Ordinary Shares through INSPIRETECH LTD. This filing establishes his initial ownership position as both a director and ", "url": "https://www.stocktitan.net/sec-filings/MJID/form-3-majestic-ideal-holdings-ltd-initial-statement-of-beneficial-ow-5040876473c6.html", "source_name": "Stock Titan", "published_at": "2026-04-08T11:09:45", "published_display": "08 Apr 2026 11:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PASW PE Ratio & Valuation, Is PASW Overvalued", "summary": "This article analyzes the valuation of Ping An Biomedical Co Ltd (PASW), stating it is currently in the \"Fair zone\" based on its forward PS ratio compared to its five-year average. It discusses various financial metrics such as Price-to-Book (P/B) ratio, Forward Free Cash Flow (F", "url": "https://intellectia.ai/en/stock/PASW/valuation", "source_name": "Intellectia AI", "published_at": "2026-04-04T14:39:06", "published_display": "04 Apr 2026 14:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PASW Stock News Today | Earnings, Events & Price Alerts", "summary": "This article provides recent news and events related to PASW (Ping An Biomedical Co.), including its stock performance and corporate actions. Key updates include shareholder approval for a significant capital structure overhaul, plans to sell 13.61 million ordinary shares, and in", "url": "https://intellectia.ai/en/stock/PASW/news", "source_name": "Intellectia AI", "published_at": "2026-04-04T12:39:06", "published_display": "04 Apr 2026 12:39", "sentiment": "positive", "sentiment_pct": 64, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PASW Financials: Revenue Breakdown, Margins & Competitor Comparison", "summary": "This article provides a financial overview of Ping An Biomedical Co Ltd (PASW), detailing its revenue breakdown, profitability margins, and key financial health indicators. It highlights the company's gross margin of 2.78%, operating margin of -43.05%, and net margin of -37.57%, ", "url": "https://intellectia.ai/en/stock/PASW/financials", "source_name": "Intellectia AI", "published_at": "2026-04-03T08:39:45", "published_display": "03 Apr 2026 08:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ping An Biomedical (PASW) director Liu Xianzhi disclosed on Form 3", "summary": "Ping An Biomedical Co., Ltd. (PASW) director Liu Xianzhi has filed a Form 3, identifying them as a director and reporting person. The filing indicates no insider purchases, sales, or other equity transactions, with zero net insider share transactions and no derivative positions o", "url": "https://www.stocktitan.net/sec-filings/MJID/form-3-majestic-ideal-holdings-ltd-initial-statement-of-beneficial-ow-093f5d5ab4c2.html", "source_name": "Stock Titan", "published_at": "2026-04-01T09:40:27", "published_display": "01 Apr 2026 09:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "All Resolutions Passed at Ping An Biomedical AGM, Clearing Path for Restructured Share Capital", "summary": "Ping An Biomedical Co., Ltd (NASDAQ: PASW) announced that its shareholders approved all five resolutions at the 2026 Annual General Meeting. These approvals lead to a major restructuring of the company's share capital, including the introduction of high-vote Class B shares, a sha", "url": "https://www.manilatimes.net/2026/03/19/tmt-newswire/globenewswire/all-resolutions-passed-at-ping-an-biomedical-agm-clearing-path-for-restructured-share-capital/2303855", "source_name": "The Manila Times", "published_at": "2026-03-23T01:38:58", "published_display": "23 Mar 2026 01:38", "sentiment": "positive", "sentiment_pct": 74, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ping An Biomedical (NASDAQ: PASW) OKs Class B shares and consolidation", "summary": "Ping An Biomedical shareholders approved a significant capital overhaul, including the creation of high-vote Class B shares and authorization for a future share consolidation. The move targets a specific transaction with major shareholder INSPIRETECH LTD, allowing them to exchang", "url": "https://www.stocktitan.net/sec-filings/MJID/6-k-majestic-ideal-holdings-ltd-current-report-foreign-issuer-31aa7fbc565e.html", "source_name": "Stock Titan", "published_at": "2026-03-19T15:10:16", "published_display": "19 Mar 2026 15:10", "sentiment": "negative", "sentiment_pct": 39, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ping An Bio clears plan to create shares with 100 votes each", "summary": "Ping An Biomedical (NASDAQ: PASW) shareholders approved all five AGM resolutions on March 18, 2026, authorizing a comprehensive capital restructure. Key actions include increasing authorized capital, creating 100,000,000 Class B shares with 100 votes each, a targeted exchange wit", "url": "https://www.stocktitan.net/news/PASW/all-resolutions-passed-at-ping-an-biomedical-agm-clearing-path-for-tjjo9rhpvjin.html", "source_name": "Stock Titan", "published_at": "2026-03-19T14:10:16", "published_display": "19 Mar 2026 14:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ping An Biomedical (PASW) director reports 599,400 indirect shares on Form 3", "summary": "Ping An Biomedical Co., Ltd. director Liu Qingxian has filed an initial insider ownership report (Form 3) disclosing an indirect ownership of 599,400 Class A Ordinary Shares through SONIC FLASH LIMITED. This filing indicates existing holdings rather than new purchases or sales. T", "url": "https://www.stocktitan.net/sec-filings/MJID/form-3-majestic-ideal-holdings-ltd-initial-statement-of-beneficial-ow-19fa05757e2a.html", "source_name": "Stock Titan", "published_at": "2026-03-18T14:08:36", "published_display": "18 Mar 2026 14:08", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ping An Biomedical (PASW) director Gao Jifeng files initial Form 3", "summary": "Gao Jifeng, a director at Ping An Biomedical Co., Ltd. (PASW), has filed an initial Statement of Beneficial Ownership of Securities (Form 3) with the SEC. The filing, dated March 18, 2026, indicates that Gao Jifeng does not beneficially own any non-derivative or derivative securi", "url": "https://www.stocktitan.net/sec-filings/MJID/form-3-majestic-ideal-holdings-ltd-initial-statement-of-beneficial-ow-82ba14881252.html", "source_name": "Stock Titan", "published_at": "2026-03-18T14:08:36", "published_display": "18 Mar 2026 14:08", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ping An Biomedical Calls March 18 AGM to Approve Dual-Class Shares and Major Share Consolidation", "summary": "Ping An Biomedical is holding its annual general meeting on March 18, 2026, to vote on significant changes to its capital structure, including the creation of dual-class shares. These changes involve increasing authorized capital to 5 billion ordinary shares, reclassifying most i", "url": "https://www.theglobeandmail.com/investing/markets/markets-news/Tipranks/669400/ping-an-biomedical-calls-march-18-agm-to-approve-dual-class-shares-and-major-share-consolidation/", "source_name": "The Globe and Mail", "published_at": "2026-03-09T01:38:57", "published_display": "09 Mar 2026 01:38", "sentiment": "negative", "sentiment_pct": 39, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PASW | Ping An Biomedical Co., Stock Data, Price & News", "summary": "This page provides comprehensive stock data for Ping An Biomedical Co., Ltd. (PASW), including real-time price, financials, insider trading activity, institutional holdings, and news. It also details the company's profile as a Cayman Islands-based holding company operating throug", "url": "https://www.quiverquant.com/stock/PASW/", "source_name": "Quiver Quantitative", "published_at": "2026-02-26T03:52:47", "published_display": "26 Feb 2026 03:52", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PASW | Ping An Biomedical Co., Institutional Ownership", "summary": "This page provides an overview of Ping An Biomedical Co., Ltd. (PASW) institutional ownership and related financial data. It details information such as insider trading activity, institutional and derivative holdings, whale activity, and features like Congress trading, corporate ", "url": "https://www.quiverquant.com/stock/PASW/institutions/", "source_name": "Quiver Quantitative", "published_at": "2026-02-22T02:52:33", "published_display": "22 Feb 2026 02:52", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "According to the latest documents disclosed by the US SEC, up to 13.6 million ordinary shares of Ping An Biomedical Co., Ltd. will be resold by its selling shareholders.", "summary": "The US SEC has disclosed that selling shareholders of Ping An Biomedical Co., Ltd. plan to resell up to 13.6 million ordinary shares. This significant share resale is expected to affect the company's equity structure, and market analysts are monitoring its potential impact on fut", "url": "https://www.bitget.com/news/detail/12560605199585", "source_name": "Bitget", "published_at": "2026-02-13T05:57:22", "published_display": "13 Feb 2026 05:57", "sentiment": "negative", "sentiment_pct": 36, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PASW SEC Filings - Ping An Biomedical 10-K, 10-Q, 8-K Forms", "summary": "This page provides access to Ping An Biomedical (PASW) SEC filings, including annual 10-K, quarterly 10-Q, and material event 8-K reports, offering detailed insights into the company's financials, operations, and risks. The company operates in both apparel supply chain management", "url": "https://www.stocktitan.net/sec-filings/PASW/", "source_name": "Stock Titan", "published_at": "2026-02-13T04:52:42", "published_display": "13 Feb 2026 04:52", "sentiment": "negative", "sentiment_pct": 38, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ping An Biomedical stock plunges after announcing $90 million investment plan By Investing.com", "summary": "Ping An Biomedical Co., Ltd (NASDAQ:PASW) stock plummeted 31% after announcing a strategic investment plan in Future Biotechnology Group. The plan involves an initial $30 million cash investment and subsequent acquisitions totaling $60 million, dependent on Future Biotechnology G", "url": "https://ca.investing.com/news/stock-market-news/ping-an-biomedical-stock-plunges-after-announcing-90-million-investment-plan-93CH-4394962", "source_name": "Investing.com Canada", "published_at": "2026-01-11T06:58:08", "published_display": "11 Jan 2026 06:58", "sentiment": "negative", "sentiment_pct": 20, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ping An Biomedical Co., Ltd Announces Strategic Investment in Future Biotechnology Group to Advance Collaborative Development of the Biopharmaceutical Industry", "summary": "Ping An Biomedical Co., Ltd (NASDAQ: PASW) announced a strategic non-binding investment memorandum with Future Biotechnology Group. The initial investment will be US$30 million in cash, with subsequent acquisitions up to US$60 million combining cash and consideration shares, cont", "url": "https://markets.financialcontent.com/ms.intelvalue/article/gnwcq-2026-1-9-ping-an-biomedical-co-ltd-announces-strategic-investment-in-future-biotechnology-group-to-advance-collaborative-development-of-the-biopharmaceutical-industry", "source_name": "FinancialContent", "published_at": "2026-01-10T12:32:12", "published_display": "10 Jan 2026 12:32", "sentiment": "positive", "sentiment_pct": 71, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ping An Biomedical (PASW) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE1xcXBwV1JES0xNdWFTLXFsQUNsYUlEdnBmbjRDcDNBSEtWRWxZSWVQTnFyb3VnNndpTnc5N29QZjMxdTgzeU1HV2k5QUJqNnJobEh3?oc=5", "source_name": "Stock Titan", "published_at": "2025-11-28T13:25:06+00:00", "published_display": "28 Nov 2025 13:25", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ping An Biomedical Co. Ltd. (NASDAQ: PASW) - Share Price", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxNNWYtN1BPZDNGWXlNSmdEdmo2bm5oaU5pS295emZ3WEw4NWE5bDg2Z3h1Ny1pdzZlU3JydmxwQUkyTHhMR0haTG9ZR256dDF5YktKaVpFSXJRWjdYdVZHTWZxX0VoS1BKVWU5RV85a2FYMmlrRVBUWXN1TTJVSzhPYUxPOEJqdGVpaHhlMUNUOTFoNkFneElHLUFxVQ?oc=5", "source_name": "intelligentinvestor.com.au", "published_at": "2025-10-02T10:15:09+00:00", "published_display": "02 Oct 2025 10:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 79, "total_relevant": 28, "sentiment_summary": {"positive": 4, "negative": 9, "neutral": 15, "score": 48, "total": 28, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 85, "events": [{"event": "general", "label": "Market update", "weight": 11.0, "count": 20}, {"event": "earnings", "label": "Earnings", "weight": 1.65, "count": 3}, {"event": "deals", "label": "Deals and strategy", "weight": 1.65, "count": 3}, {"event": "liquidity", "label": "Balance sheet", "weight": 0.55, "count": 1}, {"event": "macro", "label": "Macro sensitivity", "weight": 0.55, "count": 1}], "positive_events": 4, "negative_events": 9}, "market_context": {"has_market_context": true, "latest_close": 0.16, "latest_week": "2026-07-10", "one_week_move": -2.0, "four_week_move": -6.2, "twelve_week_move": null, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.0, "market_dynamics_buy_signal": false, "relative_strength": null, "fair_value_gap": -4.4, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "positive", "expectation_probability": 70.6667, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-2.0% over one week, -6.2% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 62, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Stock Titan", "count": 10}, {"label": "Intellectia AI", "count": 3}, {"label": "Finviz", "count": 2}, {"label": "The Globe and Mail", "count": 2}, {"label": "Quiver Quantitative", "count": 2}, {"label": "TradingKey", "count": 1}, {"label": "Investing.com Nigeria", "count": 1}, {"label": "ADVFN", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 28}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 20}, {"label": "Earnings", "count": 3}, {"label": "Deals and strategy", "count": 3}, {"label": "Balance sheet", "count": 1}, {"label": "Macro sensitivity", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "48/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "85/100 classification confidence."}, {"label": "Company focus", "value": "28", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-2.0% over one week, -6.2% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Negative", "tone": "negative", "text": "If You Invested $1,000 in Ping An Biomedical (PASW)"}], "updated_at": "2026-07-16T14:28:41.185467+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}